Nobel nomination follows Covid-19 'Exterminate!" pledge

 by EWAN LAMB

Dr Bob Jennings, one of the bosses at 'disruptive technology' business Avocet Natural Capital [ANC], has been nominated for a Nobel Prize, company chairman Martin Frost told shareholders today.

For the last six years Dr Jennings is said to have been working on the development of the 'avocet' fuel additive which will, according to Mr Frost, make electric vehicles obsolete. But neither ANC nor its predecessor Avocet Infinite, now in liquidation, have managed to produce the "wonder fuel" in bulk and market it.

The Nobel nomination revealed by Mr Frost in an update circulated to more than 600 Avocet investors comes some six months after it was announced that Dr Jennings had come up with a 'Coronavirus Killing Machine" which was due to be available five months ago. But there is still no sign of the Dalek-like apparatus being deployed to combat the pandemic.

On March 15th this year Mr Frost declared in a shareholder letter: "We note the secret to defeating Coronavirus may well dwell in Avocet’s scientific identification of how the Coronavirus replicates. Ok, the ‘Dalek’ below (the letter included an illustration of Dr Who's fictional enemy) is a rude portrait of Avocet’s Coronavirus killing machine. 

"Over the years Dr Bob Jennings has successfully filed a platform of patents to safely distribute ozone via a self-propelled ‘Dalek’ which kills not only Coronavirus but the superbug – with some modifications, Bob is creating a new family of Avocet IP Limited patents to use ozone to cleanly kill the Coronavirus in hospitals, airplanes, ships, trains, factories and shops. Dalek prototypes have proved very effective and given the correct resources and joint venture partners, Avocet believes it can have a commercial product ready for sale in May 2020."

In today's missive headed 'Moving On' Mr Frost tells his shareholders : "Incredibly happy to report, that our new investors have now provided the additional necessary funding to enable Dr. Bob Jennings and colleagues to greatly augment the non-explosive methanol additive: so Bob, Dr. Glyn Short and their teams can proceed with a methanol dual fuel (capable of running either in gasoline or diesel engines),disease free fast hydroponic growth platforms, and the unique concept for the mass production of green methanol.

"Such brilliance has prompted the nomination of Dr. Bob Jennings for a Nobel Prize. Shortly put, this new intellectual property is transformational; it stands head and shoulders above anything else in the world market."

Some investors have expressed scepticism and concern at the lack of progress which might produce a return on their investment. But ANC's chairman has assured them the arrival on the scene of wealthy anonymous financiers will allow Avocet to proceed swiftly with its plans.

Mr Frost had been seeking a 95% vote by shareholders in favour of a 'short cut' to allow changes to the company's Articles of Association asked for by the mystery investors.

But in today's update he appears to admit defeat even though he expressed confidence the 95% barrier would be breached over the weekend. He had been advised on a Shareholders' Forum not to include the six million shares he holds in the ballot count as he has apparently not paid for them.

On October 9th he wrote: "You will see that ANC Plc has moved closer to the 95% target (it was 90% in favour at the time); thus, the ANC Plc directors believe that given a few more days ANC Plc will tip the 95% figure.

"So, in turn ANC Plc will currently proceed on the premiss (sic) that this weekend will witness this 95% achievement and Monday 12th October will see the promised new Confirmation Statement based on Monday’s end’s (12th October 2020) share register – upon which our new investors will base their offers."

Instead, Mr Frost now says: " Not as good news, although most of you indicated that you would concur to a shortened notice period, I regret that as of this evening [Monday] ANC Plc has not managed to secure the 95%. The directors of ANC Plc considered increasing ANC Plc’s issued share capital by directly using the investors capital, but a quick shareholder straw poll suggested that this proposed watering down of ANC Plc equity would not be acceptable to most of you.

 

"Thus the investors and the ANC Plc directors have decided to proceed with the existing ANC Plc Articles upon which the new investors are happy with: noting that these existing articles do not offer the same degree of protection to all the shareholders (especially the smaller) as would have occurred with the proposed article revisions."  

A companies expert who has been monitoring developments at Avocet for some time told Not Just Sheep & Rugby: "The new investors are already showering the company with money without any ownership in it. And they are the kindest, most considerate investors in the world. Although many shareholders were prepared to accept £2.40 or less, they insist on paying £3 per share.

"The change to the Articles that we were told they were insisting on, is now unimportant.  And it was actually not to benefit them, but was solely in the interest of the small shareholders. Frost seems to ignore the obvious, which is that he could still get the change to the Articles approved if he simply showed it to the shareholders."